StockData
Neogen Corp logo

Neogen Corp (NEOG) stock

NEOGNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends May 31
Số liệu tài chính tới Q1 năm tài chính 2027, quý kết thúc ngày Aug 31, 2026Last filing: 10-Q on Oct 7, 2026Score 7/3053% above fair value
$11.08+0.18 (+1.65%)

Close on Nov 18, 2026Market cap $2.42BP/E –Yield –

Neogen operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Neogen's operating cash flow for the twelve months ending Aug 31, 2026 was $85.30M, down 1.9% year over year. For fiscal 2026 it was $83.20M, up 43.0% from the year before. Over ten years it grew 8.9% a year on average. The highest annual figure on record is $85.88M in fiscal 2020.

Annual operating cash flow

PeriodPeriod endValueChange
FY2026May 31, 2026$83.20M+43.0%
FY2025May 31, 2025$58.20M+64.9%
FY2024May 31, 2024$35.30M-14.0%
FY2023May 31, 2023$41.03M-39.7%
FY2022May 31, 2022$68.04M-16.1%
FY2021May 31, 2021$81.09M-5.6%
FY2020May 31, 2020$85.88M+34.5%
FY2019May 31, 2019$63.84M-7.7%
FY2018May 31, 2018$69.13M+14.7%
FY2017May 31, 2017$60.27M+70.6%
FY2016May 31, 2016$35.33M-19.3%
FY2015May 31, 2015$43.79M+102.1%
FY2014May 31, 2014$21.67M-18.4%
FY2013May 31, 2013$26.56M+19.2%
FY2012May 31, 2012$22.28M-22.8%
FY2011May 31, 2011$28.84M+3.1%
FY2010May 31, 2010$27.99M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q1 FY2027CQ3 2026Aug 31, 2026$12.90M+19.4%
Q4 FY2026CQ2 2026May 31, 2026$30.20M+84.1%
Q3 FY2026CQ1 2026Feb 28, 2026$22.70M+16.7%
Q2 FY2026CQ4 2025Nov 30, 2025$19.50M-51.6%
Q1 FY2026CQ3 2025Aug 31, 2025$10.80M–
Q4 FY2025CQ2 2025May 31, 2025$16.40M-38.8%
Q3 FY2025CQ1 2025Feb 28, 2025$19.46M–
Q2 FY2025CQ4 2024Nov 30, 2024$40.25M+156.2%
Q1 FY2025CQ3 2024Aug 31, 2024-$17.91M-177.9%
Q4 FY2024CQ2 2024May 31, 2024$26.78M-70.6%
Q3 FY2024CQ1 2024Feb 29, 2024-$30.21M–
Q2 FY2024CQ4 2023Nov 30, 2023$15.71M–
Q1 FY2024CQ3 2023Aug 31, 2023$23.01M–
Q4 FY2023CQ2 2023May 31, 2023$90.97M+346.1%
Q3 FY2023CQ1 2023Feb 28, 2023-$17.07M-359.0%
Q2 FY2023CQ4 2022Nov 30, 2022-$18.73M-204.9%
Q1 FY2023CQ3 2022Aug 31, 2022-$14.14M-160.9%
Q4 FY2022CQ2 2022May 31, 2022$20.39M-7.2%
Q3 FY2022CQ1 2022Feb 28, 2022$6.59M-43.2%
Q2 FY2022CQ4 2021Nov 30, 2021$17.85M-20.3%
Q1 FY2022CQ3 2021Aug 31, 2021$23.21M-7.7%
Q4 FY2021CQ2 2021May 31, 2021$21.97M-14.3%
Q3 FY2021CQ1 2021Feb 28, 2021$11.60M-41.4%
Q2 FY2021CQ4 2020Nov 30, 2020$22.39M+33.6%
Q1 FY2021CQ3 2020Aug 31, 2020$25.13M+6.0%
Q4 FY2020CQ2 2020May 31, 2020$25.63M+22.8%
Q3 FY2020CQ1 2020Feb 29, 2020$19.78M+90.5%
Q2 FY2020CQ4 2019Nov 30, 2019$16.75M+1.5%
Q1 FY2020CQ3 2019Aug 31, 2019$23.72M+47.5%
Q4 FY2019CQ2 2019May 31, 2019$20.88M-7.4%
Q3 FY2019CQ1 2019Feb 28, 2019$10.38M-45.8%
Q2 FY2019CQ4 2018Nov 30, 2018$16.50M+88.9%
Q1 FY2019CQ3 2018Aug 31, 2018$16.08M-13.9%
Q4 FY2018CQ2 2018May 31, 2018$22.56M+49.5%
Q3 FY2018CQ1 2018Feb 28, 2018$19.17M+22.6%
Q2 FY2018CQ4 2017Nov 30, 2017$8.74M-5.8%
Q1 FY2018CQ3 2017Aug 31, 2017$18.67M–
Q4 FY2017CQ2 2017May 31, 2017$15.09M–
Q3 FY2017CQ1 2017Feb 28, 2017$15.64M–
Q2 FY2017CQ4 2016Nov 30, 2016$9.27M–

More Neogen figures

See a number that looks wrong?